Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 160,000 shares at $150.66 ($24.0M) on 2023-03-23, disclosed to the SEC on 2023-03-24.
Seasonal sale ($24.0M) by Chief Executive Officer — this insider has traded MRNA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.13 | 3,879 | $578K | 2.4% |
| 2 | $149.13 | 3,879 | $578K | 2.4% |
| 3 | $149.84 | 18,321 | $2.7M | 11.5% |
| 4 | $149.84 | 18,321 | $2.7M | 11.5% |
| 5 | $150.76 | 14,962 | $2.3M | 9.4% |
| 6 | $150.76 | 14,962 |
| $2.3M |
| 9.4% |
| 7 | $151.67 | 2,838 | $430K | 1.8% |
| 8 | $151.67 | 2,838 | $430K | 1.8% |
| 9 | $147.71 | 6,138 | $907K | 3.8% |
| 10 | $147.71 | 6,138 | $907K | 3.8% |
| 11 | $148.62 | 18,458 | $2.7M | 11.5% |
| 12 | $148.62 | 18,458 | $2.7M | 11.5% |
| 13 | $149.61 | 5,906 | $884K | 3.7% |
| 14 | $149.61 | 5,906 | $884K | 3.7% |
| 15 | $150.66 | 7,243 | $1.1M | 4.6% |
| 16 | $150.66 | 7,243 | $1.1M | 4.6% |
| 17 | $151.53 | 996 | $151K | 0.6% |
| 18 | $151.53 | 996 | $151K | 0.6% |
| 19 | $152.55 | 1,259 | $192K | 0.8% |
| 20 | $152.55 | 1,259 | $192K | 0.8% |
| Total | $149.72 avg | 160,000 | $24.0M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |